
from
Independent International Investment Research4 page report
published Nov 06, 2009
Price
$20.00 available for immediate download
Report Overview
Search Inside
About
Independent International Inve...
Pfizer revenues continue to depict lacklustre performances due to weak sales of its blockbuster drugs such as Lipitor and Viagra, amongst others. Pfizer’s R&D pipeline continues to appear...
|
| Source: | IIR Group PLC
|
| Document ID: | GER25557SN
|
| Country: | United States
|
| Industry: | Pharmaceutical
|
| Ticker: | PFE=US
|
| Primary ISIN: | US7170811035
|
| Primary Sedol: | 2684703
|
| Free Sample: |
Click Here to Download
|
| Format: | | PDF |  |
|
Independent International Investment Research is the UK's leading source of truly impartial research and strategy for global equities and currencies.